Related Experiment Video
Updated: Feb 28, 2026

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
Lipid and hyperglycemia factors in first-ever penetrating artery infarction, a comparison between different subtypes
Shaoyang Sun1, Yanqiang Wang2, Yuge Wang3
1Department of Neurology The Affiliated Hospital of Qingdao University Qingdao China.
Insights
Branch atheromatous disease (BAD) and lipohyalinotic degeneration (LD) in penetrating artery infarction (PAI) differ. Elevated LDL-C is linked to BAD progression, while age and HbA1c correlate with pontine penetrating artery infarction.
Area of Science:
- Neurology
- Cardiovascular Research
- Metabolic Disorders
Background:
- Branch atheromatous disease (BAD) pathogenesis and progression are debated, especially compared to lipohyalinotic degeneration (LD).
- Limited research exists on lipid indices and glycometabolism in BAD within first-ever penetrating artery infarction (PAI).
Purpose of the Study:
- To investigate lipid profiles and glycometabolism in patients with PAI.
- To differentiate factors contributing to BAD versus LD in PAI.
- To explore associations between these factors and stroke progression.
Main Methods:
- Retrospective analysis of acute stroke patients with PAI admitted within 3 days.
- Utilized diffusion-weighted MRI, MRA, and/or CTA for diagnosis.
- Defined progression as ≥2-point increase in NIH Stroke Scale score; statistically analyzed clinical data.
Main Results:
- BAD diagnosed in 57% and LD in 43% of patients.
- Higher LDL-C in BAD patients (p=.013), linked to early neurological deterioration (p=.045).
- Lenticulostriate artery (LSA) infarction more common (75.1%) than pontine penetrating artery (PPA) infarction (24.9%); PPA more prevalent in BAD (34.5% vs 12.1%, p<.001).
- PPA infarction associated with older age at onset and higher HbA1c in BAD/LD patients (p=.014, p=.036).
Conclusions:
- Elevated LDL-C may contribute to intracranial BAD pathogenesis and progression.
- LSA infarction is the most frequent PAI subtype.
- Age at onset and HbA1c are associated with PPA infarction in first-ever PAI.
Background:
The pathogenesis and progression of branch atheromatous disease (BAD), which differs from lipohyalinotic degeneration (LD), remains controversial. Few studies have investigated the lipid indices and glycometabolism status factors for BAD in first-ever penetrating artery infarction (PAI).
Methods:
We retrospectively examined acute stroke patients with PAI admitted within 3 days after stroke. All patients underwent diffusion weight magnetic resonance imaging (DWI) and magnetic resonance angiography (MRA) and/or computed tomography angiography (CTA). Progression was defined as an increase by 2 point or higher in the National Institutes of Health Stroke Scale score. The characteristics, clinical data were statistically analyzed.
Results:
BAD and LD were diagnosed in 142 (57%) and 107 (43%) patients, respectively. Patients with BAD had higher low-density lipoprotein cholesterol (LDL-C) compared with those with LD (p = .013). Elevated LDL-C was related to early neurological deterioration in patients with BAD (p = .045). The percentage of lenticulostriate arterial (LSA) infarction was greater than that of the pontine penetrating arterial (PPA) infarction in acute PAI (75.1% vs. 24.9%; p < .001). PPA infarction was more prevalent in the BAD group compared with the LD group (34.5% vs. 12.1%, p < .001). The PPA infarction had older age at onset and higher HbA1c concentrations than those with the LSA infarction (p = .014, p = .036 respectively) in the BAD and LD patients, respectively.
Conclusion:
LDL-C may be associated with both the pathogenesis and progression of intracranial BAD. The LSA infarction was the most frequently subtypes in PAI. Age at onset and HbA1c seem to be closely associated with the PPA infarction of first-ever PAI.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Angina II: Classification
Angina IV: Management
Coronary Artery Disease I: Introduction

